# EDGAR Filing Document

**Accession Number:** 0001730463
**File Stem:** 0001193125-26-201422
**Filing Date:** 2026-5
**Character Count:** 2861
**Document Hash:** 2aace0f22df1b5196efb9981b85ca68e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-201422.hdr.sgml**: 20260603

**ACCESSION NUMBER**: 0001193125-26-201422

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260501

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Autolus Therapeutics plc
- **CENTRAL INDEX KEY:** 0001730463
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** THE MEDIAWORKS
- **STREET 2:** 191 WOOD LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W12 7FP
- **BUSINESS PHONE:** 44 20 3829 6230

**MAIL ADDRESS:**
- **STREET 1:** THE MEDIAWORKS
- **STREET 2:** 191 WOOD LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W12 7FP

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Autolus Therapeutics Ltd
- **DATE OF NAME CHANGE:** 20180205

![LOGO](g132407g0501222122868.jpg)

The MediaWorks 191 Wood Lane White City London W12 7FP United Kingdom VIA EDGAR

May 1, 2026

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | **Autolus Therapeutics plc**  |

---

**Registration Statement on Form S-3**

**File No. 333-295003** 

**<u>Acceleration Request</u>**

**Requested Date: May 5, 2026** 

**Requested Time: 4:00 P.M. Eastern Time**

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the "***Registrant***") hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the "***Registration Statement***") to become effective on May 5, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Christian Plaza, Courtney Thorne and William DuVal of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with William DuVal of Cooley LLP at (703) 456-8663, or in his absence, Courtney Thorne at (617) 937-2318. Thank you for your assistance with this matter.

---

| | |
|:---|:---|
|  Sincerely, | Sincerely, |
|  **AUTOLUS THERAPEUTICS PLC** | **AUTOLUS THERAPEUTICS PLC** |
| By: | /s/ Christian Itin |
|  | Christian Itin |
|  | Chief Executive Officer |

---

---

| | |
|:---|:---|
|  cc: | Alex Driggs, *Autolus Therapeutics plc* |
|  | Christian Plaza, *Cooley LLP* |
|  | Courtney Thorne, *Cooley LLP*<br> William DuVal, *Cooley LLP* |

---